Content related to Can a Tiny Particle Make a Big Impact on Diffuse Intrinsic Pontine Glioma?

Two federal grants are supporting efforts at Children’s Hospital Los Angeles to develop novel therapies for this aggressive childhood brain tumor.

Dr. Chiarelli's passion for research began as an undergraduate at Pomona College, when he worked at Los Alamos National Laboratory by invitation from a faculty mentor.

A Children’s Hospital Los Angeles team developed the test, which is the first to precisely measure how much cerebrospinal fluid is flowing through a shunt.

A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.

A CHLA oncologist is leading new research to improve outcomes for children, adolescents and young adults with relapsed or treatment-resistant germ cell tumors.

Dramatic advances in cancer research and treatment over the past two decades have made it possible for more children to survive a cancer diagnosis.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

The zebrafish is one of the most powerful biomedical research tools in use today. CHLA is using them to better understand what causes pediatric cancer.

The grant enables scientists to advance an AI-driven clinical decision support technology that will transform how doctors plan brain radiation therapy.